Literature DB >> 10582616

Vesicular monoamine transporter 1 is responsible for storage of 5-hydroxytryptamine in rat pinealocytes.

M Hayashi1, M Haga, S Yatsushiro, A Yamamoto, Y Moriyama.   

Abstract

Vesicular monoamine transporters (VMATs) are involved in chemical transduction in monoaminergic neurons and various endocrine cells through the storage of monoamines in secretory vesicles. Mammalian pinealocytes contain more 5-hydroxytryptamine (5-HT) than any other cells and are expected to contain VMAT, although no information is available so far. Upon the addition of ATP, radiolabeled 5-HT was taken up by a particulate fraction prepared from cultured rat pinealocytes. The 5-HT uptake was inhibited significantly by bafilomycin A1 (an inhibitor of vacuolar H+-ATPase), 3,5-di-tert-butyl-4-hydroxybenzylidenemalononitrile (a proton conductor), or reserpine (an inhibitor of VMAT). RT-PCR analysis suggested that VMAT type 1 (VMAT1), but not type 2, is expressed. Antibodies against VMAT1 recognized a single polypeptide with an apparent molecular mass of approximately 55 kDa, and specifically immunostained pinealocytes. VMAT1 immunoreactivity was high in the vesicular structures in the varicosities of long branching processes and was associated with 5-HT, but not with synaptophysin, a marker protein for microvesicles. The 5-HT immunoreactivity in the long branching processes disappeared upon incubation with reserpine. These results indicate that 5-HT, at least in part, is stored in vesicles other than microvesicles in pinealocytes through a mechanism similar to that of various secretory vesicles.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10582616     DOI: 10.1046/j.1471-4159.1999.0732538.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Early, H+-V-ATPase-dependent proton flux is necessary for consistent left-right patterning of non-mammalian vertebrates.

Authors:  Dany S Adams; Kenneth R Robinson; Takahiro Fukumoto; Shipeng Yuan; R Craig Albertson; Pamela Yelick; Lindsay Kuo; Megan McSweeney; Michael Levin
Journal:  Development       Date:  2006-03-22       Impact factor: 6.868

2.  Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission.

Authors:  Paul J Gasser; Christopher A Lowry; Miles Orchinik
Journal:  J Neurosci       Date:  2006-08-23       Impact factor: 6.167

3.  Role of secondary transporters and phosphotransferase systems in glucose transport by Oenococcus oeni.

Authors:  Ok Bin Kim; Hanno Richter; Tanja Zaunmüller; Sabrina Graf; Gottfried Unden
Journal:  J Bacteriol       Date:  2011-10-21       Impact factor: 3.490

4.  Serotonin modulates melatonin synthesis as an autocrine neurotransmitter in the pineal gland.

Authors:  Bo Hyun Lee; Bertil Hille; Duk-Su Koh
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-26       Impact factor: 11.205

5.  Serotonin released from amacrine neurons is scavenged and degraded in bipolar neurons in the retina.

Authors:  Kanika Ghai; Christopher Zelinka; Andy J Fischer
Journal:  J Neurochem       Date:  2009-07-08       Impact factor: 5.372

Review 6.  Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons.

Authors:  Thomas S Guillot; Gary W Miller
Journal:  Mol Neurobiol       Date:  2009-03-04       Impact factor: 5.590

7.  Essential role of vesicular nucleotide transporter in vesicular storage and release of nucleotides in platelets.

Authors:  Miki Hiasa; Natsuko Togawa; Takaaki Miyaji; Hiroshi Omote; Akitsugu Yamamoto; Yoshinori Moriyama
Journal:  Physiol Rep       Date:  2014-06-06

8.  Genetic variations in the serotoninergic system contribute to body-mass index in Chinese adolescents.

Authors:  Chunhui Chen; Wen Chen; Chuansheng Chen; Robert Moyzis; Qinghua He; Xuemei Lei; Jin Li; Yunxin Wang; Bin Liu; Daiming Xiu; Bi Zhu; Qi Dong
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.